249 related articles for article (PubMed ID: 15701284)
1. Well-differentiated neurocytoma: what is the best available treatment?
Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
[TBL] [Abstract][Full Text] [Related]
2. Defining the best available treatment for neurocytomas in children.
Rades D; Schild SE; Fehlauer F
Cancer; 2004 Dec; 101(11):2629-32. PubMed ID: 15494975
[TBL] [Abstract][Full Text] [Related]
3. Therapy of meningeal melanocytomas.
Rades D; Schild SE; Tatagiba M; Molina HA; Alberti W
Cancer; 2004 Jun; 100(11):2442-7. PubMed ID: 15160350
[TBL] [Abstract][Full Text] [Related]
4. [Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients].
Rades D; Fehlauer F; Schild S; Lamszus K; Alberti W
Strahlenther Onkol; 2003 Apr; 179(4):213-8. PubMed ID: 12707710
[TBL] [Abstract][Full Text] [Related]
5. Treatment recommendations for the various subgroups of neurocytomas.
Rades D; Schild SE
J Neurooncol; 2006 May; 77(3):305-9. PubMed ID: 16575540
[TBL] [Abstract][Full Text] [Related]
6. Treatment of atypical neurocytomas.
Rades D; Fehlauer F; Schild SE
Cancer; 2004 Feb; 100(4):814-7. PubMed ID: 14770439
[TBL] [Abstract][Full Text] [Related]
7. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas.
Rades D; Schild SE
Cancer; 2006 Mar; 106(5):1140-3. PubMed ID: 16400638
[TBL] [Abstract][Full Text] [Related]
8. Is 50 Gy sufficient to achieve long-term local control after incomplete resection of typical neurocytomas?
Rades D; Schild SE
Strahlenther Onkol; 2006 Jul; 182(7):415-8. PubMed ID: 16826361
[TBL] [Abstract][Full Text] [Related]
9. Central neurocytoma: management recommendations based on a 35-year experience.
Leenstra JL; Rodriguez FJ; Frechette CM; Giannini C; Stafford SL; Pollock BE; Schild SE; Scheithauer BW; Jenkins RB; Buckner JC; Brown PD
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1145-54. PubMed ID: 17187939
[TBL] [Abstract][Full Text] [Related]
10. Atypia predicting prognosis for intracranial extraventricular neurocytomas.
Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Lehil M; Fang S; Parsa AT
J Neurosurg; 2012 Feb; 116(2):349-54. PubMed ID: 22054208
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature.
Rades D; Schild SE
J Neurooncol; 2006 May; 77(3):311-4. PubMed ID: 16328723
[TBL] [Abstract][Full Text] [Related]
12. Dose-effect relationship for radiotherapy after incomplete resection of atypical neurocytomas.
Rades D; Fehlauer F; Ikezaki K; Schild SE
Radiother Oncol; 2005 Jan; 74(1):67-9. PubMed ID: 15683672
[TBL] [Abstract][Full Text] [Related]
13. Extraventricular neurocytomas: pathologic features and clinical outcome.
Brat DJ; Scheithauer BW; Eberhart CG; Burger PC
Am J Surg Pathol; 2001 Oct; 25(10):1252-60. PubMed ID: 11688459
[TBL] [Abstract][Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment options for paediatric ependymomas.
Vaidya K; Smee R; Williams JR
J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
[TBL] [Abstract][Full Text] [Related]
16. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
17. Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?
Yu E; Dar R; Rodrigues GB; Stitt L; Videtic GM; Truong P; Tomiak A; Ash R; Brecevic E; Inculet R; Malthaner R; Vincent M; Craig I; Kocha W; Lefcoe M
Radiother Oncol; 2004 Nov; 73(2):141-8. PubMed ID: 15542160
[TBL] [Abstract][Full Text] [Related]
18. Central neurocytoma: Clinical characteristics, patterns of care, and survival.
Dutta SW; Kaleem TA; Muller DA; Peterson J; Harrell AC; Quinones-Hinojosa A; Trifiletti DM
J Clin Neurosci; 2018 Jul; 53():106-111. PubMed ID: 29685410
[TBL] [Abstract][Full Text] [Related]
19. Central neurocytoma: 9 case series and review.
Chen CM; Chen KH; Jung SM; Hsu HC; Wang CM
Surg Neurol; 2008 Aug; 70(2):204-9. PubMed ID: 18262625
[TBL] [Abstract][Full Text] [Related]
20. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection.
Mahavadi AK; Patel PM; Kuchakulla M; Shah AH; Eichberg D; Luther EM; Komotar RJ; Ivan ME
World Neurosurg; 2020 May; 137():e176-e182. PubMed ID: 32001392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
